Pharmaceutical Intermediates - Commercial Products
| S.No. | NAME OF INTERMEDIATE | CAS NUMBER | API Application |
|---|---|---|---|
| 1 | 6-Iodoquinazolin-4(3H)-one | 16064-08-7 | LAPATINIB |
| 2 | 4-(3-Chloropropyl)morpholine | 7357-67-7 | GEFITINIB |
| 3 | Methyl-3-hydroxy-4-methoxybenzoate | 6702-50-7 | |
| 4 | Methyl-5-hydroxy-4-methoxy-2-nitrobenzoate | 215659-03-3 | |
| 5 | (S)-2((S)-4-Methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido) pentanamido)-3-phenylpropanoic acid |
868540-16-3 | CARFILZOMIB |
| 6 | N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2- pyrimidineamine | 152460-10-1 | IMATINIB |
| 7 | 4-(4-Methylpiperzinomethyl)benzoic acid.2HCl | 106261-49-8 | |
| 8 | 4-Phenoxybenzoic acid | 2215-77-2 | IBRUTINIB |
| 9 | 3-Iodo-4-methylbenzoic acid | 82998-57-0 | PONATINIB |
| 10 | Methyl-4-amino-2-methoxybenzoate | 27492-84-8 | LENVATINIB |
| 11 | 4-Amino-2-chlorobenzonitrile | 20925-27-3 | |
| 12 | 4-Phenylthiopyrrolidine-2-carboxylic acid | 105107-84-4 | ZOFENOPRIL |
| 13 | 5-Amino-2,4-ditertiarybutylphenol | 873055-58-4 | IVACAFTOR |
| 14 | 4-Oxo-1,4-dihydroquinoline-3-carboxylic acid | 13721-01-2 | |
| 15 | 4-Oxo-1,4-dihydroquinoline-3-carboxylic acid ethyl ester | 52980-28-6 | |
| 16 | 5-Bromo-2-chlorobenzoic acid | 21739-92-4 | DAPAGLIFLOZIN |
| 17 | 4-(5-Bromo-2-chlorobenzyl)phenylethyl ether | 461432-23-5 | |
| 18 | 2-Chloro-5-iodobenzoic acid | 19094-56-5 | EMPAGLIFLOZIN |
| 19 | (2-Chloro-5-iodophenyl)(4-fluorophenyl)methanone | 915095-86-2 | |
| 20 | (5-Bromo-2-chlorophenyl)(4-fluorophenyl)methanone | 915095-85-1 | |
| 21 | 4-(5-Bromo-2-chlorobenzyl)phenol | 864070-18-8 | |
| 22 | (S)-3-(2-(5-Bromo-2-chlorobenzyl)phenoxy)tetrahydrofuran | 2744280-76-8 | |
| 23 | 5-Bromo-2-methylbenzoic acid | 79669-49-1 | CANAGLIFLOZIN |
| 24 | 5-Iodo-2-methylbenzoic acid | 54811-38-0 | |
| 25 | (5-Bromo-4-methoxy-2-methylbenzyl)phenylethyl ether | LUSEOGLIFLOZIN | |
| 26 | 1-(2-Chloroacetyl)-pyrrolidine-(2S)-carbonitrile | 207557-35-5 | VILDAGLIPTIN |
| 27 | (2S)-1-[2-[(3-hydroxy-1-adamantyl)amino]-acetyl]-pyrrolidin-2-carbonitrile | 274901-16-5 | |
| 28 | Sodium-5-(methoxycarbonyl)-6-oxo-1,2,3,6-tetrahydropyridin-4-olate | 198213-15-9 | ALOSETRON |
| 29 | 3-Ethoxy-4-methoxybenzaldehyde | 1131-52-8 | APREMILAST |
| 30 | 3-Ethoxy-4-methoxy Benzonitrile | 60758-86-3 | |
| 30 | 4-Tertiarybutylbenzene sulphonamide | 6292-59-7 | BOSENTAN |
| 31 | 2-(4-Nitrophenoxyethyl)chloride | 3383-72-0 | DOFETILIDE |
| 32 | N-Methyl-4-nitrophenylethylamine.HCl | 166943-39-1 | |
| 33 | 3-(4-Hydroxyphenyl)propionic acid | 501-97-3 | ESMOLOL |
| 34 | 4-(2,4-Difluorophenyl)-4-oxobutanoic acid | 110931-77-6 | POSACONAZOLE |
| 35 | (2E,4E)-(5-(4-Methoxy-2,3,6-trimethylphenyl)-3-methylpenta-2,4-dienyl) triphenyl phosphonium bromide |
54757-44-7 | ACITRETIN |
| 36 | E-Butyl-3-methyl-4-oxobut-2-enoate | 54145-95-8 | |
| 37 | 3-(3-Phenylsulfamoylphenyl)acrylic acid | 412269-00-2 | BELINOSTAT |
| 38 | Methyl-4-acetylbenzoate | 3609-53-8 | MICAFUNGIN / MYCAMINE |
| 39 | 4-Morpholinoaniline | 2524-67-6 | REVERSINE |
| 40 | 3-Bromo-2-methylbenzoic acid | 76006-33-2 | SONIDEGIB |
| 41 | 4-Mercaptophenylacetic acid | 39361-84-7 | |
| 42 | 1-(4-Hydroxymethyl)phenylacetic acid | 73401-74-8 | NETARSUDIL |
| 43 | 1-Amino-2-methylindoline.Hydrochloride | 102789-79-7 | INDAPAMIDE |
| 44 | 4-Chloro-3-sulfamoylbenzoyl chloride | 70049-77-3 | |
| 45 | 3-(2-Chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine.HCl | 69-09-0 | CHLOROPROMAZINE |
| 46 | 2-Butyl-3-(3,5-diiodo-4-hydroxybenzoyl)benzofuran | 1951-26-4 | AMIODARONE |
| 47 | 6-Bromo-3-hydroxypyrazine-2-carboxamide | 259793-88-9 | FAVIPIRAVIR |
| 48 | Para-Menthadienol / (1R,4S)-1-Methyl-4-(prop-1-en-2-yl) cyclohex-2-enol | 22771-44-4 | CANNABIDIOL |
| 49 | 3-(4-Chlorophenyl)propionic acid | 2019-34-3 | PITOLISANT |
| 50 | 3-(Piperidin-1-yl)propan-1-ol | 104-58-5 | BIPERIDEN/ CYCRIMINE |
| 51 | (R)-N-(2-(4-Isopropyl-4,5-dihydroxazol-2-yl)-6-methylphenyl) methane sulfonamide |
871360-40-6 | ERIBULIN |
| 52 | 4-(4-Nitrophenyl)butyric acid | 5600-62-4 | CHLORAMBUCIL |
| 53 | 5-(N,N-Dibenzylglycyl)salicylamide | 30566-92-8 | LABETALOL |
| 54 | 3-cyano-4-isopropoxybenzoic acid | 258273-31-3 | OZANIMOD |
| 55 | 4-bromobenzene sulfonyl chloride | 98-58-8 | |
| 56 | methyl 3-piperidin-1-ylpropanoate | 23973-93-5 | |
| 57 | 4-chloro-3-nitro-5-sulfamoylbenzoic acid | 22892-96-2 | BUMETANIDE |
| 58 | 3-(3, 4-Dihydroxyphenyl)propionic acid | 1078-61-1 |
Pharmaceutical Intermediates - Under Development
| S.No. | NAME OF INTERMEDIATE | CAS NUMBER | API Application |
|---|---|---|---|
| 1 | 2-(2-Ethoxyphenyl)-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one | 224789-21-3 | VARDENAFIL |
| 2 | 3-morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one | 545445-44-1 | APIXABAN |
| 3 | Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate | 27143-07-03 | |
| 4 | (R)-2-((4-Nitrophenethyl)amino)-1-phenylethanol Hydrochloride | 521284-21-9 | MIRABEGRON |
| 5 | 4-Bromo Methyl Benzoate | 2417-72-3 | |
| 6 | 3-Amino pthalic Acid HCL | 5434-20-8 | APRIMILAST |
| 7 | 10-Methoxy-5H-dibenzo[b,f]azepine / 10-Methoxy Iminostilbene | 4698-11-7 | OXCARBAZEPINE/CARBAMAZEPINE |